On September 20, 2021, the board of directors of Ocular Therapeutix, Inc., following the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Merilee Raines to serve as a member of the Board to fill a vacancy on the Board and as a member of the Audit Committee of the Board. The election was effective as of September 20, 2021, following which the Board consisted of eight members with no vacancies. Ms. Raines was designated as a Class III member of the Board to serve until the 2023 annual meeting of the stockholders of the Company and thereafter until her successor has been duly elected and qualified, or until her earlier death, resignation or removal. Ms. Raines, served as Chief Financial Officer of IDEXX Laboratories, Inc., from October 2003 until her retirement in May 2013. Ms. Raines also served as Executive Vice President of IDEXX from July 2012 until her retirement in May 2013. Ms. Raines has served as a member of the boards of directors of Watts Water Technologies, Inc., since 2011; and of TransMedics Group, Inc., since January 2021. Previously, Ms. Raines also served as a member of the boards of directors of Benchmark Electronics, Inc., from May 2018 until her resignation in June 2021.